Non-radiographic Versus Radiographic AxSpA: What's in a Name?

Overview

Journal Rheumatology (Oxford)

Publisher Oxford University Press

Specialty Rheumatology

Date 2020 Oct 14

PMID 33053190

Citations 14

Authors

Xabier Michelena

Clementina Lopez-Medina

Helena Marzo-Ortega

Affiliations

Soon will be listed here.

Abstract

Axial spondyloarthritis is a heterogeneous inflammatory condition with variable clinical presentations and outcomes. The complexity of its diagnosis and absence of biomarkers hamper the development of diagnostic criteria with the risk of misuse of the available classification criteria in clinical practice and its consequences. Axial spondyloarthritis should be regarded as a continuum in which some patients, but not all, will have a more severe phenotype characterized by progression into new bone formation and joint fusion. Growing understanding of the factors that might drive disease progression and treatment response will allow for better characterization of treatment options and outcome for each affected individual. The aim of this review is to update the current evidence of what is axial spondyloarthritis and to highlight the need to focus on the concept rather than its classification.

Citing Articles

Between uncertainty and destiny: the patient journey in axial spondyloarthritis care from the perspectives of patients and their relatives.

May S, Nordmann G, Gabb F, Boy K, Wagner M, Ohm N BMC Rheumatol. 2025; 9(1):14.

PMID: 39934914 PMC: 11818133. DOI: 10.1186/s41927-025-00465-3.

Long-term safety and sustained efficacy of bimekizumab in patients with ankylosing spondylitis (radiographic axial spondyloarthritis): 5-year results from BE AGILE (phase 2b) and its open-label extension.

Deodhar A, Navarro-Compan V, Poddubnyy D, Gensler L, Ramiro S, Tomita T RMD Open. 2025; 11(1).

PMID: 39890205 PMC: 11792280. DOI: 10.1136/rmdopen-2024-005081.

Osteoporosis in axial radiographic spondyloarthritis: diagnostic limitations of bone mineral density and the need for comprehensive fracture risk assessment.

Zuchowski P, Dura M, Jeka D, Wojciechowski R, Bierwagen M, Kulakowski M Reumatologia. 2025; 62(6):466-474.

PMID: 39866305 PMC: 11758111. DOI: 10.5114/reum/194107.

Validity and reliability of the Turkish version of Exercise Benefits/ Barriers Scale: Perceived exercise benefits and barriers of patients with different axial spondyloarthritis subtypes.

Sarac D, Durak Ediboglu E, Kaya D, Duran G, Akatay E, Gucenmez S Arch Rheumatol. 2024; 39(3):447-458.

PMID: 39507848 PMC: 11537679. DOI: 10.46497/ArchRheumatol.2024.10720.

Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From a Randomized, Placebo-Controlled, Phase 3 Study.

Deodhar A, Supronik J, Kivitz A, Valenzuela G, Kapur K, Rohrer S Arthritis Rheumatol. 2024; 77(2):163-170.

PMID: 39300513 PMC: 11782106. DOI: 10.1002/art.42993.

References

de Winter J, van Mens L, van der Heijde D, Landewe R, Baeten D . Prevalence of peripheral and extra-articular disease in ankylosing spondylitis versus non-radiographic axial spondyloarthritis: a meta-analysis. Arthritis Res Ther. 2016; 18:196. PMC: 5009714. DOI: 10.1186/s13075-016-1093-z. View

Sieper J, Hu X, Black C, Grootscholten K, van den Broek R, Kachroo S . Systematic review of clinical, humanistic, and economic outcome comparisons between radiographic and non-radiographic axial spondyloarthritis. Semin Arthritis Rheum. 2016; 46(6):746-753. DOI: 10.1016/j.semarthrit.2016.09.002. View

Bacchiega A, Balbi G, Ochtrop M, Andrade F, Levy R, Baraliakos X . Ocular involvement in patients with spondyloarthritis. Rheumatology (Oxford). 2017; 56(12):2060-2067. DOI: 10.1093/rheumatology/kex057. View

Corli J, Flipo R, Philippe P, Bera-Louville A, Behal H, Wibaux C . Tumor Necrosis Factor-α Inhibition in Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: Treatment Response, Drug Survival, and Patient Outcome. J Rheumatol. 2015; 42(12):2376-82. DOI: 10.3899/jrheum.150372. View

Song I, Weiss A, Hermann K, Haibel H, Althoff C, Poddubnyy D . Similar response rates in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis after 1 year of treatment with etanercept: results from the ESTHER trial. Ann Rheum Dis. 2012; 72(6):823-5. DOI: 10.1136/annrheumdis-2012-202389. View

Kang K, Kim I, Yoon M, Hong Y, Park S, Ju J . Fat Metaplasia on Sacroiliac Joint Magnetic Resonance Imaging at Baseline Is Associated with Spinal Radiographic Progression in Patients with Axial Spondyloarthritis. PLoS One. 2015; 10(8):e0135206. PMC: 4535979. DOI: 10.1371/journal.pone.0135206. View

Baraliakos X, Regel A, Kiltz U, Menne H, Dybowski F, Igelmann M . Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis. Rheumatology (Oxford). 2017; 57(9):1541-1547. DOI: 10.1093/rheumatology/kex318. View

Poddubnyy D, Brandt H, Vahldiek J, Spiller I, Song I, Rudwaleit M . The frequency of non-radiographic axial spondyloarthritis in relation to symptom duration in patients referred because of chronic back pain: results from the Berlin early spondyloarthritis clinic. Ann Rheum Dis. 2012; 71(12):1998-2001. DOI: 10.1136/annrheumdis-2012-201945. View

Baraliakos X, Kiltz U, Peters S, Appel H, Dybowski F, Igelmann M . Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis. Rheumatology (Oxford). 2016; 56(1):95-102. DOI: 10.1093/rheumatology/kew367. View

10.

Song I, Hermann K, Haibel H, Althoff C, Poddubnyy D, Listing J . Consistently Good clinical response in patients with early axial spondyloarthritis after 3 years of continuous treatment with etanercept: longterm data of the ESTHER trial. J Rheumatol. 2014; 41(10):2034-40. DOI: 10.3899/jrheum.140056. View

11.

Lopez-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A . Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis. RMD Open. 2019; 5(2):e001108. PMC: 6890393. DOI: 10.1136/rmdopen-2019-001108. View

12.

Poddubnyy D, Callhoff J, Spiller I, Listing J, Braun J, Sieper J . Diagnostic accuracy of inflammatory back pain for axial spondyloarthritis in rheumatological care. RMD Open. 2019; 4(2):e000825. PMC: 6336095. DOI: 10.1136/rmdopen-2018-000825. View

13.

Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W . Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol. 1988; 15(7):1109-14. View

14.

Bray T, Lopes A, Fisher C, Ciurtin C, Sen D, Hall-Craggs M . Sacroiliac Joint Ankylosis in Young Spondyloarthritis Patients Receiving Biologic Therapy: Observation of Serial Magnetic Resonance Imaging Scans. Arthritis Rheumatol. 2018; 71(4):594-598. PMC: 6915840. DOI: 10.1002/art.40750. View

15.

Jovani V, Blasco-Blasco M, Ruiz-Cantero M, Pascual E . Understanding How the Diagnostic Delay of Spondyloarthritis Differs Between Women and Men: A Systematic Review and Metaanalysis. J Rheumatol. 2016; 44(2):174-183. DOI: 10.3899/jrheum.160825. View

16.

Sengupta R, Marzo-Ortega H, McGonagle D, Wadeley A, Bennett A . Short-term Repeat Magnetic Resonance Imaging Scans in Suspected Early Axial Spondyloarthritis Are Clinically Relevant Only in HLA-B27-positive Male Subjects. J Rheumatol. 2017; 45(2):202-205. DOI: 10.3899/jrheum.170171. View

17.

Nieto R, Plasencia Rodriguez C, Peiteado Lopez D, Villalba Yllan A, Balsa Criado A, Navarro-Compan V . Are we treating women patients with real axial spondyloarthritis?. Semin Arthritis Rheum. 2019; 50(3):432-435. DOI: 10.1016/j.semarthrit.2019.11.011. View

18.

Rueda-Gotor J, Llorca J, Corrales A, Blanco R, Fuentevilla P, Portilla V . Subclinical atherosclerosis is not increased in patients with non-radiographic axial spondyloarthritis. Clin Exp Rheumatol. 2016; 34(1):159-60. View

19.

Exarchou S, Lie E, Lindstrom U, Askling J, Forsblad-dElia H, Turesson C . Mortality in ankylosing spondylitis: results from a nationwide population-based study. Ann Rheum Dis. 2015; 75(8):1466-72. DOI: 10.1136/annrheumdis-2015-207688. View

20.

Lopez-Medina C, Molto A . Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis. Best Pract Res Clin Rheumatol. 2018; 32(2):241-253. DOI: 10.1016/j.berh.2018.10.006. View